Based on your previous selection, you have been forwarded to the website for International.

XL CBFB/MYH11 plus

Translocation/Dual Fusion Probe

Order Number
D-5126-100-OG
Package Size
100 µl (10 Tests)
Labels
  
Chromosome
16
Regulatory Status
IVDD

IVDR Certification

This probe is IVDR-certified in compliance with the Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR).

MetaSystems Probes has already certified a wide range of FISH probes, according to IVDR.

This product remains IVDD-certified until further notice.

Please use the switch to change to the IVDR product.

IVDDIVDRDiscover all IVDR-certified products

Product Description

XL CBFB/MYH11 plus

XL CBFB/MYH11 plus consists of a green-labeled probe hybridizing to the MYH11 gene region at 16p13.1 and an orange-labeled probe hybridizing to the CBFB gene region at 16q22.

Probe maps for selected products have been updated. These updates ensure a consistent presentation of all gaps larger than 10 kb including adjustments to markers, genes, and related elements. This update does not affect the device characteristics or product composition. Please refer to the list to find out which products now include updated probe maps.

Probe map details are based on UCSC Genome Browser GRCh37/hg19, with map components not to scale.

Need assistance or a quote?

Clinical Details

Clinical Applications

  • Acute Myelogenous Leukemia (AML)
Need assistance or a quote?

Images

XL CBFB/MYH11 plus

XL CBFB/MYH11 plus hybridized to bone marrow cells. One aberrant interphases is shown. A partial insertion of MYH11 into CBFB results in two green, one orange and one green/orange colocalization/fusion signal.

Need assistance or a quote?

Expected Patterns

Expected Pattern 1

Normal Cell:
Two green (2G) and two orange (2O) signals.

Expected Pattern 2

Aberrant Cell (typical results):
One green (1G), one orange (1O), and two green-orange colocalization/fusion signals (2GO) resulting from an inversion or reciprocal translocation with breakpoints in the respective loci.

Need assistance or a quote?

Literature

  • Fröhling et al (2005) Heamatologica 90:194-199
  • Van Obbergh et al (2014) Cancer Genetics 207:231-232
  • Zhang et al (2017) Adv in Mod Onc Res 3:12-14

Downloads

News